Response by Valgimigli and Gargiulo to Letter Regarding Article, “A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We thank Damen and colleagues for their interest in our review on antiplatelet therapy and the contemporary role of aspirin for secondary prevention in patients with coronary artery disease undergoing coronary stent implantation.1 We agree with their comments and appreciate they shared the “less is more” concept.1
We also appreciate their suggestion not to forget previous evidence generated with vitamin k antagonist agents, which does potentially support the concept that oral anticoagulants may effectively replace an antiplatelet agent as long-term secondary prevention measure. As emphasized by Damen and colleagues, nonvitamin k antagonists offer …